In Focus

Home/ In Focus

ESID's important announcements, news, articles...

Joint statement on the current epidemics of new Coronavirus

Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on a joint statement to provide guidance in advising patients with primary immunodeficiency under our care in the current COVID-19 context.

PID Survey update - COVID-19

The Survey summary on COVID-19 in PID patients can be viewed  here.

IPOPI – ESID Joint Statement: The use of monoclonal antibody treatment for patients with PID in the context of the COVID-19 pandemic

 IPOPI ESID Statement IPOPI – ESID Joint Statement The use of monoclonal antibody treatment for patients with PID in the context of the COVID-19 pandemic 11 November 2021 The role of monoclonal antibody (mAb or moAb) therapies in the treatme...